ENDOMETRIOID ENDOMETRIAL CANCER
Clinical trials for ENDOMETRIOID ENDOMETRIAL CANCER explained in plain language.
Never miss a new study
Get alerted when new ENDOMETRIOID ENDOMETRIAL CANCER trials appear
Sign up with your email to follow new studies for ENDOMETRIOID ENDOMETRIAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Immunotherapy plus chemo shows promise for tough uterine cancer
Disease control Recruiting nowThis study is testing whether adding the immunotherapy drug camrelizumab to standard chemotherapy before surgery can help shrink advanced endometrial cancer. About 39 women with stage III or IV disease will receive the combination, then undergo surgery. The main goal is to see ho…
Matched conditions: ENDOMETRIOID ENDOMETRIAL CANCER
Phase: PHASE2 • Sponsor: Women's Hospital School Of Medicine Zhejiang University • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC
-
New drug cocktail aims to outsmart resistant uterine cancer
Disease control Recruiting nowThis phase 2 trial tests whether combining hormone therapy (letrozole) with a targeted drug (abemaciclib), and possibly adding metformin or gedatolisib, can control estrogen-receptor-positive endometrial cancer that has returned or spread. The study enrolls adults with this cance…
Matched conditions: ENDOMETRIOID ENDOMETRIAL CANCER
Phase: PHASE2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
New drug combo aims to stall endometrial cancer in High-Risk patients
Disease control Recruiting nowThis study tests whether two drugs, abemaciclib and letrozole, can help keep advanced or recurrent endometrial cancer from getting worse. About 32 people with a specific type of estrogen-sensitive cancer will take these pills daily after initial treatment. The goal is to see if t…
Matched conditions: ENDOMETRIOID ENDOMETRIAL CANCER
Phase: PHASE2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
New hope for Obesity-Linked endometrial cancer: experimental combo enters human trials
Disease control Recruiting nowThis early-stage trial tests the safety of combining two drugs, ONC201 and atezolizumab, in 58 women with advanced or recurrent endometrial cancer. The study includes both obese and non-obese participants to see if body weight affects treatment. The goal is to find the best dose …
Matched conditions: ENDOMETRIOID ENDOMETRIAL CANCER
Phase: PHASE1 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New combo therapy targets hard-to-treat endometrial cancer
Disease control Recruiting nowThis study tests a combination of two drugs, nab-sirolimus and letrozole, in 29 people with advanced or recurrent endometrioid endometrial cancer that cannot be removed by surgery. The goal is to see if the combination shrinks tumors or slows cancer growth. Participants take both…
Matched conditions: ENDOMETRIOID ENDOMETRIAL CANCER
Phase: PHASE2 • Sponsor: Aadi Bioscience, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC